Clinical trial
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients…
NCT00353262 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00353262 |
|---|---|
| Title | A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. |
| Official title | An Open-label Study to Assess the Pharmacokinetic Interaction Between Xeloda and Oxaliplatin in Patients With Metastatic Colorectal Cancer. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Avastin, Oxaliplatin, capecitabine [Xeloda] |
| Enrollment | 36 |
| Start date | Jul 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Jul 18, 2006 |
| Last update posted | Mar 4, 2016 |
| Countries | Canada |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: